Get started
EXACT SCIENCES COREXACT SCIENCES COREXACT SCIENCES COR

EXACT SCIENCES COR

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

EXK chart


Full chart

EXK upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.19 B‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.993 CHF
Net income (FY)
‪−171.88 M‬ CHF
Revenue (FY)
‪2.10 B‬ CHF
Shares float
‪182.28 M‬
Beta (1Y)
−0.33

Employees


Employees (FY)
‪6.6 K‬
Change (1Y)
+200 +3.13%
Revenue / Employee (1Y)
‪378.75 K‬ CHF
Net income / Employee (1Y)
‪−30.93 K‬ CHF

About Exact Sciences Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Kevin T. Conroy
Website
exactsciences.com
Headquarters
Madison
Founded
1995
FIGI
BBG00LVDBGJ2
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

EXK news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

EXK highest yielding bonds


EXAS4806408
Exact Sciences Corporation 0.375% 15-MAR-2027
Yield to maturity
5.97%
Maturity date
Mar 15, 2027
EXAS4957195
Exact Sciences Corporation 0.375% 01-MAR-2028
Yield to maturity
4.96%
Maturity date
Mar 1, 2028
EXAS5793007
Exact Sciences Corporation 1.75% 15-APR-2031
Yield to maturity
3.72%
Maturity date
Apr 15, 2031
EXAS5549793
Exact Sciences Corporation 2.0% 01-MAR-2030
Yield to maturity
2.66%
Maturity date
Mar 1, 2030
EXAS4586328
Exact Sciences Corporation 1.0% 15-JAN-2025
Yield to maturity
1.76%
Maturity date
Jan 15, 2025

Explore more bonds 

Sparks


Curated watchlists where EXK is featured.

See all sparks 

Frequently Asked Questions


The current price of EXK is 60.299 CHF — it has increased by 36.52% in the past 24 hours. Watch EXACT SCIENCES COR stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange EXACT SCIENCES COR stocks are traded under the ticker EXK.
We've gathered analysts' opinions on EXACT SCIENCES COR future price: according to them, EXK price has a max estimate of 74.46 CHF and a min estimate of 52.56 CHF. Watch EXK chart and read a more detailed EXACT SCIENCES COR stock forecast: see what analysts think of EXACT SCIENCES COR and suggest that you do with its stocks.
EXK reached its all-time high on Jun 19, 2023 with the price of 85.285 CHF, and its all-time low was 34.642 CHF and was reached on Jun 16, 2022. View more price dynamics on EXK chart.
See other stocks reaching their highest and lowest prices.
EXK stock is 26.75% volatile and has beta coefficient of −0.33. Track EXACT SCIENCES COR stock price on the chart and check out the list of the most volatile stocks — is EXACT SCIENCES COR there?
Today EXACT SCIENCES COR has the market capitalization of ‪8.23 B‬, it has decreased by −0.61% over the last week.
Yes, you can track EXACT SCIENCES COR financials in yearly and quarterly reports right on TradingView.
EXACT SCIENCES COR is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
EXK earnings for the last quarter are −0.18 CHF per share, whereas the estimation was −0.17 CHF resulting in a −7.20% surprise. The estimated earnings for the next quarter are −0.29 CHF per share. See more details about EXACT SCIENCES COR earnings.
EXACT SCIENCES COR revenue for the last quarter amounts to ‪600.53 M‬ CHF, despite the estimated figure of ‪607.44 M‬ CHF. In the next quarter, revenue is expected to reach ‪615.85 M‬ CHF.
EXK net income for the last quarter is ‪−32.40 M‬ CHF, while the quarter before that showed ‪−14.21 M‬ CHF of net income which accounts for −127.99% change. Track more EXACT SCIENCES COR financial stats to get the full picture.
No, EXK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has ‪6.60 K‬ employees. See our rating of the largest employees — is EXACT SCIENCES COR on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXACT SCIENCES COR EBITDA is ‪−18.60 M‬ CHF, and current EBITDA margin is −3.05%. See more stats in EXACT SCIENCES COR financial statements.
Like other stocks, EXK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXACT SCIENCES COR stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXACT SCIENCES COR technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXACT SCIENCES COR stock shows the buy signal. See more of EXACT SCIENCES COR technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.